Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.
Saved in:
| Title: | Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier. |
|---|---|
| Authors: | Di K; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.)., Lloyd GK; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.)., Abraham V; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.)., MacLaren A; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.)., Burrows FJ; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.)., Desjardins A; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.)., Trikha M; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.)., Bota DA; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.). |
| Source: | Neuro-oncology [Neuro Oncol] 2016 Jun; Vol. 18 (6), pp. 840-8. Date of Electronic Publication: 2015 Dec 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26681765 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Di+K%22">Di K</searchLink>; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.).<br /><searchLink fieldCode="AU" term="%22Lloyd+GK%22">Lloyd GK</searchLink>; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.).<br /><searchLink fieldCode="AU" term="%22Abraham+V%22">Abraham V</searchLink>; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.).<br /><searchLink fieldCode="AU" term="%22MacLaren+A%22">MacLaren A</searchLink>; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.).<br /><searchLink fieldCode="AU" term="%22Burrows+FJ%22">Burrows FJ</searchLink>; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.).<br /><searchLink fieldCode="AU" term="%22Desjardins+A%22">Desjardins A</searchLink>; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.).<br /><searchLink fieldCode="AU" term="%22Trikha+M%22">Trikha M</searchLink>; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.).<br /><searchLink fieldCode="AU" term="%22Bota+DA%22">Bota DA</searchLink>; University of California, Irvine, California (K.D., V.A., D.A.B.); Triphase Accelerator Corporation, San Diego, California (G.K.L., A.M., F.J.B, M.T.); The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina (A.D.). – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2016 Jun; Vol. 18 (6), pp. 840-8. <i>Date of Electronic Publication: </i>2015 Dec 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26681765 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/neuonc/nov299 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 840 Titles: – TitleFull: Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Di K – PersonEntity: Name: NameFull: Lloyd GK – PersonEntity: Name: NameFull: Abraham V – PersonEntity: Name: NameFull: MacLaren A – PersonEntity: Name: NameFull: Burrows FJ – PersonEntity: Name: NameFull: Desjardins A – PersonEntity: Name: NameFull: Trikha M – PersonEntity: Name: NameFull: Bota DA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2016 Jun Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1523-5866 Numbering: – Type: volume Value: 18 – Type: issue Value: 6 Titles: – TitleFull: Neuro-oncology Type: main |
| ResultId | 1 |
